We investigated 219 deaths from myocardial infarction in women under the age of 50. Their histories were compared with those of living age-matched controls selected from the same general practices. The frequency of use of oral contraceptives during the month before death was significantly greater in the group with infarction than during the corresponding month in the control group and the average duration of use was longer. No information on cigarette smoking was available but the proportion of women being treated for hypertension or diabetes was greater among those who died than among the controls. This did not alter the overall conclusion that the risk of fatal myocardial infarction was greater in the women using oral contraceptives, particularly in the older age groups.
Introduction
Inman and Vessey's report to the Committee on Safety of Drugs on deaths from pulmonary embolism and coronary and cerebral thrombosis in women of childbearing age was published in 1968.1 In the cases of pulmonary embolism and cerebral thrombosis a strong relationship was found with the use of oral contraceptives when these disorders occurred in the absence of predisposing conditions. More of the women who died from coronary thrombosis in the absence of predisposing conditions had also been using oral contraceptives than would have been expected from the experience of the control group, but for this condition the difference was not quite significant and a definite association was considered not proved. Later studies2 3 were not conclusive and we thought it desirable to undertake a further investigation of deaths from myocardial infarction in 1973 . 410 according to the eighth revision of the International Classification of Diseases (myocardial infarction and synonymous terms) were obtained from the Registrar General. A total of 726 were received. All deaths in women under the age of 40 years, every second death in the 40-44-year age group, and every fifth death in the 45-49-year age group were selected for the study, giving a total of 277 cases (table I) . Selection was made consecutively as batches of certificates were received. The remaining 219 deaths were investigated by the committee's medical field officers, as a result of which a further 66 cases were excluded. In 37 cases evidence for the diagnosis of myocardial infarction was thought to be inadequate. Deaths were included in the final analysis only when the diagnosis was substantiated by necropsy findings or a history of typical chest pain together with electrocardiographic or enzymatic confirmation as defined by the World Health Organization. 4 In 23 cases (10-5%) a necropsy carried out after the death certificate had been completed or (less often) other evidence suggested that death was attributable to a different cause. A further six cases were excluded because the wrong sex, age, or year of death had been given on the certificate. The remaining 153 deaths provide the basis for this report. In 104 cases the diagnosis was substantiated at necropsy. Procedure Forty-eight members of the committee's staff of medical officers took part in the field work. During the investigation of each death one of them completed a questionnaire as fully as possible with the aid of the general practitioner and any other doctors who had attended the patient during her terminal illness. Since the general practitioner's records had usually been returned to the local executive council after the patient's death he was asked to retrieve them before being interviewed. These major sources of information were often supplemented by hospital case notes, family planning clinic records, necropsy reports, and court records supplied by a coroner. The possible sources of bias which might have influenced the relationships observed in this study include the fact that 58 (21 %) of the 277 deaths selected for study could not be investigated because the general practitioner was not traced or was unable to collaborate. It seems unlikely, however, that bias could have been introduced for this reason because control patients were selected only from the practice lists of co-operating doctors. Another possible source is that there must have been some deaths due to myocardial infarction in the relevant sex and age groups of which we were not notified because of incorrect death certification or administrative difficulties. Indeed, we are aware of two such deaths-one which occurred in a woman using an oral contraceptive, which was notified as an adverse reaction to the Committee on Safety of Medicines, and another in a patient with longstanding diabetes. (These two cases were not, of course, included in our analysis.) Only five of the 31 deaths in women using oral contraceptives at the time of death were, however, reported to the Committee on Safety of Medicines, and this finding together with the fact that deaths were included only when the diagnosis was confirmed at necropsy or substantiated by unequivocal clinical and laboratory findings make the possibility that myocardial infarction was simply diagnosed more often in oral contraceptive users extremely unlikely. It is, furthermore, interesting that the frequency of oral contraceptive use was the same in patients with infarction whose cause of death was confirmed at necropsy as in those in whom the diagnosis depended on clinical and laboratory findings.
Selection of Cases
Of great importance is the fact that the control population should be representative of the general population of women of childbearing age with regard to their oral contraceptive practice.
Comparison with a recent national survey, however, suggests that the current oral contraceptive use in our control population under 40 years of age was greater than might have been expected, 9 l 0 and this, if true, would have tended to reduce the association found between myocardial infarction and oral contraceptive use. A possible explanation might be an "overmatching" phenomenon if general practitioners had tended to be either regular oral contraceptive prescribers or not. An association between myocardial infarction and oral contraceptive use would then have lead the investigator, when following up deaths from infarction, to practices where the prescribing of these drugs was more frequent, and hence the control population selected from these practices would tend to include more users than the general population of the same age group.
The procedure adopted here certainly resulted in more intensive investigation of the patients with infarction than of the control women, in that information concerning the dead patients was also sought from hospital case notes, family planning clinic records, necropsy reports, and court records. It may therefore be considered that information on oral contraceptive use was more likely to be obtained for these patients than for the living controls. Of the 41 patients found to have been using oral contraceptives, however, 39 had this information recorded in their general practitioners' records, which provided the primary source of information for both the patients with myocardial infarction and the controls.
An investigation of this type can provide little evidence of the mechanism by which oral contraceptives give rise to a risk of myocardial infarction. The fact that the patients with infarction had been using them longer on average than the control patients may suggest that their use contributes to the atherogenic processes. It must be noted, however, that current use of oral contraceptives was more important than use at some time in the past. Moreover, 83% of the necropsy reports on women who had been using oral contraceptives at the time of death mentioned a thrombus in the coronary arteries, whereas only 55% of the reports on patients who had not been using the preparations mentioned this finding. This difference is significant at the 500 level. The latter finding should be interpreted with great caution, since the techniques for examining these arteries are critical and could clearly not be controlled in any way in a study of this kind. These two observations, however, weigh in favour of the hypothesis that a thrombotic tendency rather than increased atheroma explains, at least to some extent, the increased risk attributed to the use of these drugs. P=0 .05 P=0-02 P=042 P = 0-002
The data derived from this study and information on the structure of the female population of England and Wales derived from the Registrar General's report make it possible to estimate the mortality from myocardial infarction in women who use oral contraceptives and in those who do not. In the 30-39-year age group the yearly death rate in women not using these preparations is estimated to be 1-9 per 100 000 compared with 5-4 per 100 000 in women who are using them. In the 40-44-year age group the yearly death rates are 11-7 and 54-7 per 100 000 respectively.* It seems, then, that the risk of death from myocardial infarction was increased about 2-8 times in current users of oral contraceptives aged 30-39 years and about 417 times in women aged 40-44 years.
In absolute terms the attributable mortality was considerably lower in women aged 30-39 years than in those aged 40-44 years, there being an excess of 3-5 deaths per 100 000 users yearly in the former group and 43 per 100 000 users yearly in the latter group. These estimates of risk are similar to the increased risk of non-fatal infarction estimated by Mann et al.1" but still need to be interpreted with caution, as a number of assumptions have necessarily had to be made in their calculation and the margin of error is likely to be fairly wide. We do, nevertheless, consider them to be helpful in providing a crude estimate of risk of death from myocardial infarction in women currently using oral contraceptives. *These data are too few to justify making estimates for women aged [45] [46] [47] [48] [49] years, in whom the yearly mortality rate in 1973 Little attention has been paid to the maintenance of labour after such regimen. We have studied the modem process of labour stimulation to see whether a stage is reached beyond which oxytocin requirements are greatly reduced.
Patients and Methods
Labour was induced in 83 multiparous and 77 primiparous women between 266 and 294 days of gestation. The indications for induction are shown in table I. All the fetuses presented cephalically. Except for women excluded because of possible cephalopelvic disproportion consecutive patients were treated. 
